Qicheng Chen

Qicheng Chen

Auto-generated profile, based on publicly available information

Qicheng Chen

Department of Perioperative Research Center of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2018 in Trials
Verified
Journal Article
Open access
PDF file
HGHuachan Gan
Huachan Gan
JLJinxuan Lin
Jinxuan Lin
ZJZhi Jiang
Zhi Jiang
QCQicheng Chen
Qicheng Chen
LCLixing Cao
Lixing Cao
CZChen Zhiqiang
Chen Zhiqiang
Most patients who undergo abdominal surgery recover bowel movements within a week; however, some suffer prolonged intestinal paralysis or postoperative ileus (POI) leading to complications, such as infection and intestinal adhesions, which can extend hospitalization and increase readmission rates, and consequently increasing healthcare costs. Chinese medicine is effective for accelerating the recovery of gastrointestinal function after abdominal surgery. Xiangbin prescription (XBP) is the standard prescription for this purpose in our hospital; however, randomized controlled trials of it have not yet been conducted. This double-blind, randomized controlled clinical trial aims to recruit patients who have undergone abdominal surgery and experienced postoperative dysmotility to evaluate the efficacy and safety of XBP for preventing POI and accelerating recovery. The research will tackle the common problem of slow recovery of gastrointestinal function after surgery. The participants will be patients who undergo laparoscopic radical resection of rectal carcinoma or laparoscopic panhysterectomy of a benign lesion. Primary outcome measures will be time to first flatus, defecation, normal bowel sounds, and liquid/semi-liquid/general diet. Good Clinical Practice (GCP) standards of efficacy and safety will also be evaluated, along with objective investigation of the mechanism of action of ghrelin. This pivotal trial will be a standardized, scientific, clinical trial designed to evaluate the use of XBP for the recovery of gastrointestinal function after surgery, and it will conform to international standards for clinical trials for the recognition of traditional Chinese medicine. Chinese Clinical Trial Registry, ID: ChiCTR-TRC-14004156 . Registered on 3 January 2014.

28 October 2025 in International Journal of Surgery
Verified
Journal Article
Open access
ZJZhi Jiang
Zhi Jiang
XLXing Li
Xing Li
ZSZhuo Shao
Zhuo Shao
HTHailin Tang
Hailin Tang
JWJianwei Wu
Jianwei Wu
ZMZu-Bing Mei
Zu-Bing Mei
Background: Enhanced recovery after surgery (ERAS) protocols have transformed perioperative care in laparoscopic colorectal surgery, aiming to optimize patient outcomes. However, heterogeneity in reported outcomes across randomized controlled trials (RCTs) limits evidence synthesis and clinical application. A core outcome set (COS) is urgently needed to standardize outcome reporting and enhance research comparability. This study aims to systematically map outcomes reported in ERAS RCTs for laparoscopic colorectal surgery, providing a foundation for developing a tailored COS specific to this subfield. Methods: Following PRISMA guidelines, we searched PubMed, Embase, and the Cochrane Library for RCTs published from inception to April 2025, assessing ERAS protocols in laparoscopic colorectal surgery. Studies were included if they were RCTs comparing ERAS interventions with standard care or other ERAS variants. Data on study characteristics, interventions, and reported outcomes were extracted and categorized into domains using narrative synthesis. Outcome frequency and measurement variability were analyzed. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Results: From 57 included RCTs ( n = 7502 patients), 86 unique outcomes were identified across 9 domains: gastrointestinal recovery (25.6%, e.g., time to first flatus, 45.6% of studies), postoperative pain (18.6%, e.g., Visual Analogue Scale pain scores, 31.6%), hospital stay (14.0%, e.g., length of stay, 38.6%), postoperative complications (15.1%), physical function (9.3%), immune and inflammatory response (7.0%), patient-reported outcomes (4.7%), postoperative nausea and vomiting (3.5%), and economic outcomes (2.3%). Outcome definitions and measurement tools varied widely, with no consistent standardization. Conclusions: This study highlights heterogeneity in ERAS outcome reporting, emphasizing the need for a COS. The identified domains and outcomes provide a foundation for standardizing research, improving evidence quality, and guiding clinical practice.

30 December 2019 in Research Square
Verified
Preprint
Open access
HGHuachan Gan
Huachan Gan
JLJinxuan Lin
Jinxuan Lin
ZJZhi Jiang
Zhi Jiang
QCQicheng Chen
Qicheng Chen
LCLixing Cao
Lixing Cao
CZChen Zhiqiang
Chen Zhiqiang
Background and purpose Abdominal surgery is the main department of gynaecology operation. Accelerating the recovery of gastrointestinal function after surgery can not only make patients early recovery diet, but also can reduce the common complications such as pelvic adhesion. It’s important to the rehabilitation and prognosis of patients. The Chinese medicine has been proven to accelerate the recovery of bowel function after the gynecologic abdominal surgery. Most of the indicators used to evaluate gastrointestinal motility recovery are scattered, and there is no standardized evaluation criterion so far. We found that there is not a scale for evaluating the gastrointestinal motility in perioperative period after reviewing a large number of literatures. The Postoperative Clinical Evaluation Criteria for Gastrointestinal Motility (PCECGM) became the local standard of Guangdong province (DB44/t 1581-2015) issued by the quality supervision bureau of Guangdong province in 2015, and a clinical evaluation now is necessary. Study design Cohort study (Diagnostic); Level of evidence, 2. Methods This prospective study was performed in the department of gynecology department at the Guangdong Province Traditional Medical Hospital from Mar. 2015 and Jun. 2017. Patients who diagnosed with benign lesion after laparoscopic total hysterectomy were included in this study. The purpose of this research was to evaluate reliability, validity and responsiveness of the PCECGM. Results 202 patients were included in this study, and the response , completion rate, complete time of the scale were 100%, 99.01% and(95.49士16.69)min, showing the good acceptability. The Cronbach’s Alpha coefficient and spearman-brown were 0.62 and 0.71 respectively. KMO is 0.58, and Bartlett's Test of Sphericity is 181.01, P<0.001. Two factors were extracted according to the factor analysis, and the cumulative contribution rate is 56.33%. The total score of the patients after treatment was significantly higher, P<0.001, and standardized effect value and standardized reaction mean were all 1.32, indicating a high degree of reactivity. Conclusions The properties of “Postoperative clinical evaluation criteria for gastrointestinal motility” are acceptable. It is an effective tool for the evaluation of gastrointestinal motility after the gynecologic abdominal surgery. Introduction Perioperative gastrointestinal dysfunction refers to the perioperative gastrointestinal function of all aspects such as sports secretion defense digestion absorption excretion disorders or weakened. Gastrointestinal motility disorder is the main cause of postoperative gastrointestinal dysfunction. At present, there is no uniform standard for postoperative gastrointestinal motility evaluation in clinical practice. It’s important to the rehabilitation and prognosis of patients. The Postoperative Clinical Evaluation Criteria for Gastrointestinal Motility (PCECGM) became the local standard of Guangdong province (DB44/t 1581-2015) issued by the quality supervision bureau of Guangdong province in 2015.

1 June 2013
Verified
Journal Article
Closed access
ZJZhi Jiang
Zhi Jiang
QCQi-Cheng Chen
Qi-Cheng Chen
LCLixing Cao
Lixing Cao
ZCZhi-Qiang Chen
Zhi-Qiang Chen